Chinese Medicine Treatment for Afatinib-Induced Paronychia

研究成果: 雜誌貢獻文章同行評審

摘要

Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.

原文英語
頁(從 - 到)7327359
期刊Case Reports in Oncological Medicine
2017
DOIs
出版狀態已發佈 - 2017

指紋 深入研究「Chinese Medicine Treatment for Afatinib-Induced Paronychia」主題。共同形成了獨特的指紋。

引用此